Literature DB >> 10069880

Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease.

M Majori1, M Corradi, A Caminati, G Cacciani, S Bertacco, A Pesci.   

Abstract

BACKGROUND: Previous studies have provided evidence for an inflammatory process in the large airways of subjects with chronic obstructive pulmonary disease (COPD), consisting predominantly of activated T cells. No data are available on the TH1 /TH2 T-cell cytokine pattern in this disease.
OBJECTIVE: We sought to characterize the TH1 /TH2 T-cell cytokine pattern in subjects with COPD.
METHODS: We examined the IFN-gamma and IL-4 expression in peripheral blood CD4+ and CD8+ T cells from 20 patients with COPD and 25 control subjects by using a flow cytometric method of intracellular cytokine detection. We also examined the expression of 2 surface activation markers (CD25 and HLA-DR) on peripheral blood CD4+ and CD8+ T cells.
RESULTS: There was an increased percentage of IFN-gamma-producing cells (30.3% [range, 12.9% to 60.4%] vs 19.1% [range, 4% to 31.2%], P =.003) and a decreased percentage of IL-4-producing cells (4.55% [range, 0.6% to 11.3%] vs 9.5% [2.1% to 21.3%], P =.0008) among peripheral blood CD4+ T cells from the patients with COPD compared with control subjects. There was no significant difference between the 2 groups in the percentage of peripheral blood CD8+ T cells producing IFN-gamma or IL-4 or in the percentage of peripheral blood CD4+ and CD8+ T cells expressing CD25 and HLA-DR.
CONCLUSION: These findings provide evidence for a TH1 -like immune response of peripheral blood CD4+ T cells in subjects with COPD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069880     DOI: 10.1016/s0091-6749(99)70471-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  38 in total

1.  Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+).

Authors:  M J Leckie; G R Jenkins; J Khan; S J Smith; C Walker; P J Barnes; T T Hansel
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

Review 2.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Transgenic Mice Overexpressing Vitamin D Receptor (VDR) Show Anti-Inflammatory Effects in Lung Tissues.

Authors:  Masaki Ishii; Yasuhiro Yamaguchi; Kyoko Isumi; Sumito Ogawa; Masahiro Akishita
Journal:  Inflammation       Date:  2017-12       Impact factor: 4.092

4.  Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression.

Authors:  Eitan Halper-Stromberg; Jeong H Yun; Margaret M Parker; Ruth Tal Singer; Amit Gaggar; Edwin K Silverman; Sonia Leach; Russell P Bowler; Peter J Castaldi
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

5.  Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.

Authors:  M Eric Gershwin; Carlo Selmi; Howard J Worman; Ellen B Gold; Mitchell Watnik; Jessica Utts; Keith D Lindor; Marshall M Kaplan; John M Vierling
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

6.  CD4+ T-Cell Profiles and Peripheral Blood Ex-Vivo Responses to T-Cell Directed Stimulation Delineate COPD Phenotypes.

Authors:  Mustimbo E P Roberts; Brandon W Higgs; Philip Brohawn; Fernanda Pilataxi; Xiang Guo; Michael Kuziora; Russell P Bowler; Wendy I White
Journal:  Chronic Obstr Pulm Dis       Date:  2015-08-23

7.  Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.

Authors:  Christine M Freeman; MeiLan K Han; Fernando J Martinez; Susan Murray; Lyrica X Liu; Stephen W Chensue; Timothy J Polak; Joanne Sonstein; Jill C Todt; Theresa M Ames; Douglas A Arenberg; Catherine A Meldrum; Christi Getty; Lisa McCloskey; Jeffrey L Curtis
Journal:  J Immunol       Date:  2010-04-28       Impact factor: 5.422

8.  Peripheral Blood T-Cell Populations in COPD, Asymptomatic Smokers and Healthy Non-Smokers in Indian subpopulation- A Pilot Study.

Authors:  Rashmi Teresa K Mathai; Smitha Bhat
Journal:  J Clin Diagn Res       Date:  2013-04-29

9.  Treatment with intranasal iloprost reduces disease manifestations in a murine model of previously established COPD.

Authors:  Matthew R Lammi; Mohamed A Ghonim; Kusma Pyakurel; Amarjit S Naura; Salome V Ibba; Christian J Davis; Samuel C Okpechi; Kyle I Happel; Bennett P deBoisblanc; Judd Shellito; A Hamid Boulares
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-02-05       Impact factor: 5.464

10.  Decreased expression of interleukin 13 in human lung emphysema.

Authors:  A Boutten; M Bonay; S Laribe; G Leseche; Y Castier; V Leçon-Malas; M Fournier; G Durand; M Aubier; M Dehoux; B Crestani
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.